Lv51
1070 积分 2022-06-07 加入
Re-evaluating antibody–drug conjugate linker stability: assessment, interpretation, and clinical translation
14天前
已完结
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
1个月前
已完结
An overview of disease models for NLRP3 inflammasome over-activation
1个月前
已完结
Combination therapies and other therapeutic approaches targeting the NLRP3 inflammasome and neuroinflammatory pathways: a promising approach for traumatic brain injury
1个月前
已完结
用于注册临床试验中基于流式细胞术的生物分析方法和样品检测的最佳实践(2025版)
1个月前
已完结
中美附条件批准抗肿瘤药物上市前后临床药理学研究的比较分析
1个月前
已完结
抗程序性死亡配体-1单克隆抗体在食蟹猴中单个核细胞的受体占位方法学比较
1个月前
已完结
抗PD-L1单克隆抗体在食蟹猴全血和PBMC两种样本的受体占位方法学比较
1个月前
已关闭
受体占有率在药物开发中的意义及其基于流式细胞术的方法建立
1个月前
已完结
Establishing a flow cytometry‐based tissue receptor occupancy assay for an anti‐oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease
2个月前
已完结
皖公网安备34019202002308
